Michela Maur

1.2k total citations
26 papers, 666 citations indexed

About

Michela Maur is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michela Maur has authored 26 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Michela Maur's work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Michela Maur is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Michela Maur collaborates with scholars based in Italy, United States and Spain. Michela Maur's co-authors include Pierfranco Conté, Antonio Frassoldati, Massimo Dominici, Chiara Tomasello, Maria Vittoria Dieci, Elena Barbieri, Giulia Grisendi, Filippo de Braud, Federica Bertolini and Giorgia Guaitoli and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and European Journal of Cancer.

In The Last Decade

Michela Maur

25 papers receiving 651 citations

Peers

Michela Maur

ONCOL

PRM

IMMUN

GENET

Wojciech Rogowski Poland

Gabriella Sammarelli Italy

Angela Pennisi United States

Chie-Schin Shih United States

Ellen M. Basu United States

Carrie Brownstein United States

L. Iglesias Spain

JT Chang United States

Robin E. Norris United States

Raju Vaddepally United States

Wojciech Rogowski Poland

Michela Maur

286 ×0.7

ONCOL

204 ×1.0

180 ×0.9

PRM

80 ×0.7

IMMUN

40 ×0.4

GENET

Citations per year, relative to Michela Maur Michela Maur (= 1×) peers Wojciech Rogowski

Countries citing papers authored by Michela Maur

Since Specialization

Citations

This map shows the geographic impact of Michela Maur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michela Maur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michela Maur more than expected).

Fields of papers citing papers by Michela Maur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michela Maur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michela Maur. The network helps show where Michela Maur may publish in the future.

Co-authorship network of co-authors of Michela Maur

This figure shows the co-authorship network connecting the top 25 collaborators of Michela Maur. A scholar is included among the top collaborators of Michela Maur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michela Maur. Michela Maur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Santoro, Armando, Eric Assénat, Thomas Yau, et al.. (2024). A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma. JHEP Reports. 6(4). 101021–101021. 5 indexed citations

Bertolini, Federica, Elisabetta Petracci, Stefania Bettelli, et al.. (2023). Genomic profiling in advanced NSCLC in Italy: First results of NERoNE (NSCLC Emilia Romagna Next Generation Sequencing Evaluation) project.. Journal of Clinical Oncology. 41(16_suppl). e21077–e21077.

Aramini, Beatrice, Valentina Masciale, Giulia Grisendi, et al.. (2022). Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence. Cancers. 14(4). 976–976. 75 indexed citations

Guaitoli, Giorgia, et al.. (2022). Thyroid Function Impairment after Chemo-Immunotherapy for Advanced Nsclc: A Single Institutional Retrospective Report. Immunotherapy. 14(9). 675–682. 2 indexed citations

Guaitoli, Giorgia, Federica Bertolini, Stefania Bettelli, et al.. (2021). Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations. International Journal of Molecular Sciences. 22(23). 12867–12867. 18 indexed citations

Piacentini, Federico, Ilenia Mastrolia, Valentina Masciale, et al.. (2021). Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature. Cancers. 13(19). 4894–4894. 8 indexed citations

Curigliano, Giuseppe, Miguel Martín, Komal Jhaveri, et al.. (2021). Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study. European Journal of Cancer. 151. 49–62. 20 indexed citations

Omarini, Claudia, Michela Maur, Gabriele Luppi, et al.. (2020). Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!. European Journal of Cancer. 133. 29–32. 32 indexed citations

Felip, Enriqueta, Filippo de Braud, Michela Maur, et al.. (2019). Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study. Journal of Thoracic Oncology. 15(3). 392–403. 60 indexed citations

10.

Guaitoli, Giorgia, Cinzia Baldessari, Michela Maur, et al.. (2019). Treating cancer with immunotherapy in HIV-positive patients: A challenging reality. Critical Reviews in Oncology/Hematology. 145. 102836–102836. 11 indexed citations

11.

Rossi, Giulio, Irene Bargellini, Martina Bonifazi, et al.. (2019). Optimised Tumour Sampling and Processing by a Multidisciplinary Approach for an Accurate Diagnosis in Non-Small Cell Lung Cancer. 90–99. 3 indexed citations

12.

Hong, David S., Patrick Schöffski, Aitana Calvo, et al.. (2018). Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients (pts) with advanced malignancies.. Journal of Clinical Oncology. 36(15_suppl). 3012–3012. 61 indexed citations

13.

Agarwal, Neeraj, Jean-Pascal Machiels, Cristina Suárez, et al.. (2016). Phase I Study of the Prolactin Receptor Antagonist LFA102 in Metastatic Breast and Castration-Resistant Prostate Cancer. The Oncologist. 21(5). 535–536i. 48 indexed citations

14.

Catania, Chiara, Michela Maur, Rossana Berardi, et al.. (2015). The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer. Cell Adhesion & Migration. 9(1-2). 14–21. 52 indexed citations

15.

Altomonte, Maresa, Anna Maria Di Giacomo, Paola Queirolo, et al.. (2013). Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme. Journal of Experimental & Clinical Cancer Research. 32(1). 82–82. 20 indexed citations

16.

Maur, Michela, Chiara Tomasello, Antonio Frassoldati, et al.. (2011). Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma. Journal of Clinical Oncology. 30(6). e76–e78. 91 indexed citations

17.

Grisendi, Giulia, Cecilia Annerén, Elena Veronesi, et al.. (2010). GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion. Cytotherapy. 12(4). 466–477. 54 indexed citations

18.

Sessa, Cristiana & Michela Maur. (2007). Ovarian Cancers in Pregnancy. PubMed. 178. 75–78. 5 indexed citations

19.

Maur, Michela & Cristiana Sessa. (2007). Review: new biological insights in early clinical studies. Hematological Oncology. 25(2). 53–57. 3 indexed citations

20.

Frassoldati, Antonio, et al.. (2005). Predictive Value of Biologic Parameters for Primary Chemotherapy in Operable Breast Cancer. Clinical Breast Cancer. 6(4). 315–324. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact